Quality measurement and accountability programs can be powerful tactics to advance health equity for sexual and gender minority groups. Ensuring that measures in key quality programs do not exclude these populations is an important step, but quality measurement and accountability efforts must move beyond inclusion to advance improvement in care and outcomes.
This panel presentation will recognize recent advances in measure inclusivity and discuss remaining gaps. Experts in quality measurement, health equity and the LGBTQ patient experience will discuss how to move from inclusion to improvement by focusing on opportunities to stratify existing measures to identify and address disparities and to develop and implement quality measures that address care needs and outcome inequities experienced by transgender and gender-diverse patients.
Panelists will discuss the potential for developing or implementing measures in specific clinical areas of particular relevance to sexual and gender minorities, such as HIV and certain mental health conditions. Drawing from the National LGBT Cancer Network, the presentation will highlight specific opportunities to use measurement to meet the needs of cancer patients.
The session will also reflect on potential pitfalls of implementing measures designed to drive improvement in care for gender-diverse populations. Presenters will facilitate audience discussion to solicit ideas for both expanding measurement and promoting improved care while avoiding adverse outcomes.
Theresa Schmidt, Real Chemistry
NFN Scout, National LGBT Cancer Network